Asian private equity investor PAG has reportedly teamed with CX Partners and Samara Capital to buy a controlling stake in Indian drug maker Anjan Drug.
Asian private equity investor PAG has reportedly teamed with CX Partners and Samara Capital to buy a controlling stake in Indian drug maker Anjan Drug.